PDCD1 and diffuse large B-cell lymphoma: Regarding PD-1, receptor expression was detected in 39.5–68.6% of DLBCL cases [85], and data support the notion that a high number of PD-1+ tumour-infiltrating lymphocytes (TILs) are associated with favourable clinical features and prognosis [72,86].